Canada· CA-DIN-02132680

COLESTID TABLETS

A colestipol product containing colestipol hydrochloride, registered in Canada by PFIZER CANADA ULC. The same ATC class is registered in 7 of our 19 countries.

ATC C10AC02

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedCOLESTID TABLETSATCC10AC02REGISTER NO.CA-DIN-02132680PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Colestipol is registered in 7 of 19 countries.

Countries holding a registration under ATC C10AC02 (colestipol), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 5 of them publish a price we can compare per daily dose

Colestipol · ATC C10AC02

7 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Norwayprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
COLESTIPOL HYDROCHLORIDE
Manufacturer
PFIZER CANADA ULC
Country
Canada (CA)
ATC code
C10AC02
ATC class
Colestipol
Defined daily dose
20 g, O
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

70 interactions on record for colestipol.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Colestipol · interactions on record

70 records

  • 3 severe
  • 54 moderate
  • 8 minor

Most severe, free to view

  • Mycophenolic acidL04AA06severe
  • TeriflunomidL04AA31severe
  • TeriflunomideL04AK02severe
  • Chenodeoxycholic acidA05AA01moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colestipol in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colestipol products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/76bd9de1-03eb-4967-8bba-be3ac356a8f7
GET /v1/drugs/76bd9de1-03eb-4967-8bba-be3ac356a8f7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02132680",
  "form": "TABLET",
  "class": "Human",
  "routes": [
    "ORAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "C10AC02",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "18627",
  "strengths": [
    "1 G"
  ],
  "ahfs_class": null,
  "substances": [
    "COLESTIPOL HYDROCHLORIDE"
  ],
  "product_categorization": null
}

See everything about colestipol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.